Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment

Despite the effort to develop efficient targeted drug delivery for lung cancer treatment, the outcome remains unsatisfactory with a survival rate of 15% after 5 years of diagnosis. Inhalation formulation is an ideal alternative that could ensure the direct deposition of chemotherapeutics to the lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wing-Hin, Loo, Ching-Yee, Traini, Daniela, Young, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822152/
https://www.ncbi.nlm.nih.gov/pubmed/33375181
http://dx.doi.org/10.3390/pharmaceutics13010009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822152/
https://www.ncbi.nlm.nih.gov/pubmed/33375181
http://dx.doi.org/10.3390/pharmaceutics13010009

Ejemplares similares